|
Volumn 34, Issue 9, 2007, Pages 1509-1512
|
Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma
a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTINEOPLASTIC AGENT;
BETA INTERFERON;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
LAMIVUDINE;
MONOCLONAL ANTIBODY;
PREDNISONE;
RITUXIMAB;
UNCLASSIFIED DRUG;
VINCRISTINE;
VIRUS DNA;
ARTICLE;
B CELL LYMPHOMA;
CASE REPORT;
DRUG EFFECT;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
MIDDLE AGED;
PHYSIOLOGY;
VIROLOGY;
VIRUS ACTIVATION;
ANTI-HIV AGENTS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DNA, VIRAL;
DOXORUBICIN;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
INTERFERON-BETA;
LAMIVUDINE;
LYMPHOMA, B-CELL;
MIDDLE AGED;
PREDNISONE;
VINCRISTINE;
VIRUS ACTIVATION;
|
EID: 35348926755
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|